Aequus Pharmaceuticals (CVE:AQS) Share Price Passes Below 50 Day Moving Average – Time to Sell?

Aequus Pharmaceuticals Inc. (CVE:AQS)’s share price crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of C$0.01 and traded as low as C$0.01. Aequus Pharmaceuticals shares last traded at C$0.01, with a volume of 100,000 shares trading hands.

Aequus Pharmaceuticals Stock Down 37.5%

The stock has a market capitalization of C$663,150.00, a price-to-earnings ratio of -0.50 and a beta of -0.02. The company has a quick ratio of 0.46, a current ratio of 0.07 and a debt-to-equity ratio of 138.88. The stock has a 50 day moving average price of C$0.01 and a 200 day moving average price of C$0.01.

About Aequus Pharmaceuticals

Aequus Pharmaceuticals Inc operates as a specialty pharmaceutical company in Canada. The company markets ZIMED PF, a preservative-free bimatoprost ophthalmic solution. It also develops a range of prescription-free dry eye products under the OPTASE name; and REV-0100 for the treatment of stargardt disease. The company was incorporated in 2013 and is headquartered in Vancouver, Canada.